Literature DB >> 16380542

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.

Paul Poirier, Thomas D Giles, George A Bray, Yuling Hong, Judith S Stern, F Xavier Pi-Sunyer, Robert H Eckel.   

Abstract

Obesity is becoming a global epidemic in both children and adults. It is associated with numerous comorbidities such as cardiovascular diseases (CVD), type 2 diabetes, hypertension, certain cancers, and sleep apnea/sleep-disordered breathing. In fact, obesity is an independent risk factor for CVD, and CVD risks have also been documented in obese children. Obesity is associated with an increased risk of morbidity and mortality as well as reduced life expectancy. Health service use and medical costs associated with obesity and related diseases have risen dramatically and are expected to continue to rise. Besides an altered metabolic profile, a variety of adaptations/alterations in cardiac structure and function occur in the individual as adipose tissue accumulates in excess amounts, even in the absence of comorbidities. Hence, obesity may affect the heart through its influence on known risk factors such as dyslipidemia, hypertension, glucose intolerance, inflammatory markers, obstructive sleep apnea/hypoventilation, and the prothrombotic state, in addition to as-yet-unrecognized mechanisms. On the whole, overweight and obesity predispose to or are associated with numerous cardiac complications such as coronary heart disease, heart failure, and sudden death because of their impact on the cardiovascular system. The pathophysiology of these entities that are linked to obesity will be discussed. However, the cardiovascular clinical evaluation of obese patients may be limited because of the morphology of the individual. In this statement, we review the available evidence of the impact of obesity on CVD with emphasis on the evaluation of cardiac structure and function in obese patients and the effect of weight loss on the cardiovascular system.

Entities:  

Mesh:

Year:  2005        PMID: 16380542     DOI: 10.1161/CIRCULATIONAHA.106.171016

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  804 in total

Review 1.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

2.  Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats.

Authors:  Pedro L Prieto-Hontoria; Patricia Pérez-Matute; Marta Fernández-Galilea; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Eur J Nutr       Date:  2012-06-05       Impact factor: 5.614

3.  IgG receptor FcγRIIB plays a key role in obesity-induced hypertension.

Authors:  Nathan C Sundgren; Wanpen Vongpatanasin; Brigid-Meghan D Boggan; Keiji Tanigaki; Ivan S Yuhanna; Ken L Chambliss; Chieko Mineo; Philip W Shaul
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

Review 4.  Reductions in cardiovascular risk after bariatric surgery.

Authors:  Fethi Benraouane; Sheldon E Litwin
Journal:  Curr Opin Cardiol       Date:  2011-11       Impact factor: 2.161

5.  DNA methylation in inflammatory genes among children with obstructive sleep apnea.

Authors:  Jinkwan Kim; Rakesh Bhattacharjee; Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Oscar Sans Capdevila; Yang Wang; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2011-11-10       Impact factor: 21.405

6.  Towns with extremely low mortality due to ischemic heart disease in Spain.

Authors:  María José Medrano; Raquel Boix; Alba Palmera; Rebeca Ramis; Iñaki Galán; Gonzalo López-Abente
Journal:  BMC Public Health       Date:  2012-03-09       Impact factor: 3.295

7.  Effect of Caloric Restriction on Metabolic Dysfunction of Young Rapacz Familial Hypercholesterolemic Swine (Sus scrofa).

Authors:  Nell A Bekiares; Andrea S Chen; Dhanansayan Shanmuganayagam; Adrienne Dardenne Meyers; Thomas D Crenshaw; Christian G Krueger; Jess D Reed
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

8.  Are there differences in quality of life, symptomatology and functional capacity among different obesity classes in women with fibromyalgia? The al-Ándalus project.

Authors:  V A Aparicio; V Segura-Jiménez; I C Alvarez-Gallardo; F Estévez-López; D Camiletti-Moirón; P A Latorre; M Delgado-Fernández; A Carbonell-Baeza
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

9.  A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.

Authors:  Jun Wu; James S Pankow; Russell P Tracy; Kari E North; Richard H Myers; Mary E Feitosa; Michael A Province; Ingrid B Borecki
Journal:  Obesity (Silver Spring)       Date:  2008-12-25       Impact factor: 5.002

10.  Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery.

Authors:  Rouzbeh Mostaedi; Denise E Lackey; Sean H Adams; Stephen A Dada; Zahid A Hoda; Mohamed R Ali
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.